InsidersTradesSigma
Follow the 삼양바이오팜 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼양바이오팜 has published 10 public disclosures. Market capitalisation: €332bn. The latest transaction was disclosed on 19 March 2026 (Other). Among the most active insiders: 김윤. All data is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
n/a
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 March 2026
Declarations10 total
Other
10 of 10 declarations
关于 삼양바이오팜
Samyang Biopharm 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于药品的开发和制造。